Using machine learning to improve flu vaccines
Machine Learning to Modulate Influenza Immunity
This study is working on using smart computer technology to create better flu vaccines that can help protect you longer and more effectively against the virus.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11017530 on NIH RePORTER |
What this research studies
This research focuses on developing advanced computational tools that utilize machine learning to create more effective vaccines against influenza. By integrating artificial intelligence with traditional biology, the project aims to design vaccines that provide broader and longer-lasting immunity. The approach includes innovative strategies such as targeting specific parts of the virus and refining vaccine candidates based on experimental feedback. Patients may benefit from vaccines that are more effective in preventing influenza infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at higher risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a more effective flu vaccine that provides broader protection against various strains of the virus.
How similar studies have performed: Other research has shown promise in using machine learning for vaccine development, indicating that this approach could lead to significant advancements in immunization strategies.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Meiler, Jens — Vanderbilt University
- Study coordinator: Meiler, Jens
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.